Ophthalmology Doctors in Battle Creek, MI Accepting Medicare
6 Ophthalmology doctors found. Showing 1 - 6
 Dr. Larry Marvin Vanderplas, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3600 Capital Ave Sw, Ste 203, Battle Creek, MI 49015 Phone: 269-979-6383 Fax: 269-979-6381 |
Dr. Randall C Stout, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3600 Capital Ave Sw, Ste 203, Battle Creek, MI 49015 Phone: 269-979-6383 Fax: 269-979-6381 |
Joseph A Crapotta, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 363 Fremont St Ste 301, Battle Creek, MI 49017 Phone: 866-435-8935 |
 Dr. Marie Burke, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3600 Capital Ave Sw Ste 203, Battle Creek, MI 49015 Phone: 269-979-6383 Fax: 269-979-6381 |
James L Keller, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2845 Capital Ave Sw, Suite 202, Battle Creek, MI 49015 Phone: 269-979-6305 Fax: 269-979-6329 |
Dr. James Edwin Macvicar, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1 Hiawatha Cove Trail, Battle Creek, MI 49015 Phone: 269-963-6130 |
News Archive
Study: Most uncommon infections and major vascular events are likely to be misdiagnosed
New research provides estimates of diagnostic error and serious misdiagnosis-related harm rates for each of the five most frequently misdiagnosed major vascular events, infections, and cancers in the U.S.
New study investigates effects of influenza among pregnant women
This spring, pregnant women in Bergen and Oslo will be invited to take part in the Norwegian Influenza Study (NorFlu). The aim is to find out how influenza in pregnancy affects maternal health and childhood development. NorFlu will also study any implications of vaccination during pregnancy.
An overview on fitness to drive for patients with cardiovascular diseases
People suffering from various types of cardiovascular disease are subject to a certain accident risk when driving a vehicle on the road. High blood pressure, coronary heart disease and cardiac insufficiency might be grounds for a (temporary) driving ban.
FDA approves new drug application for NEXTERONE Premixed Injection
Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration has approved the supplemental new drug application for NEXTERONE (amiodarone HCl) Premixed Injection, the first and only premixed intravenous (IV) bag formulation of the antiarrhythmic agent amiodarone IV.
› Verified 1 days ago
Internal Medicine
Family Medicine
Psychiatry & Neurology
Pediatrics
Obstetrics & Gynecology
Emergency Medicine
Anesthesiology
Surgery
Physical Medicine & Rehabilitation
Orthopaedic Surgery